Cannabidiol (CBD) derived from hemp is legal and available to everyone in all 50 U.S. states, including Maryland, regardless if a state has an operational medical marijuana or adult use program.
Maryland’s medical cannabis commission has been hampered by pending legislation and legal battles since state lawmakers passed medical cannabis legislation in 2014. After a more than 2-year delay, the Natalie M. LaPrade Maryland Medical Cannabis Commission has said it expects to have medical cannabis available to patients sometime this summer. However, the patient registry has yet to open, and as The Cannabist reports, residents are concerned that one of the slowest medical marijuana program rollouts could get delayed even further.
The Maryland Medical Cannabis Commission was initially overwhelmed with an onslaught of applications from businesses interested in growing, processing and dispensing the medical cannabis. After a lengthy process, the commission pre-approved a selection of 30 growers and processors last August, but was instantly accused of not following a state mandate requiring a racially-diverse group of business owners and had to pause to evaluate whether it failed to follow the law.
Two emergency bills have been introduced by the Legislative Black Caucus to address the lack of ownership diversity. To examine whether discrimination does exist in the medical cannabis industry the state would conduct a study and the 15-member commission would be overhauled to reflect the diverse makeup of Maryland. State lawmakers are currently considering the bills, but according to Sarah Hoyt, director of government affairs for the commission, any changes at this point would “substantially delay the availability of medical cannabis to qualifying patients,” by as much as two years.
Once Maryland’s medical marijuana program is implemented, qualified patients that have obtained a doctor’s recommendation will be legally allowed to possess up to 120 grams of non-smokable marijuana products, including extracts, lotions, ointments, tinctures, and other forms of cannabis that can be vaporized.
Because marijuana and its extracts, including the psychoactive compound tetrahydrocannabinol (THC), are classified as Schedule I substances under the federal Controlled Substances Act, patients in the U.S. only have legal access to medical marijuana if they reside in one of the 28 states that have passed laws establishing state-regulated programs. Even the non-psychoactive compound cannabidiol (CBD), when derived from marijuana, is subject to federal law.
CBD that is derived from the seeds and stalk of imported hemp, however, is excluded from the federal law. Therefore, people in Maryland and the remaining 49 U.S. states are legally allowed to purchase and consume CBD hemp oil products, without a prescription and regardless of whether a state has established medical or adult use cannabis laws.
This includes Medical Marijuana, Inc.’s Real Scientific Hemp Oil-XTM (RSHO-XTM) CBD hemp oil and its other CBD hemp oil products. Medical Marijuana, Inc. offers CBD in the form of pure hemp oil, liquids, tinctures, capsules, gum, and body care products. Those in Maryland and throughout the U.S. can learn more about our available CBD hemp oil products here and purchase CBD hemp oil products for home delivery at our online store.
This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.